• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清素1A受体激动剂丁螺环酮对健康志愿者认知和情绪加工的行为影响。

The behavioural effects of the serotonin 1A receptor agonist buspirone on cognition and emotional processing in healthy volunteers.

作者信息

Smith Alexander L W, Hamilton Sorcha, Murphy Susannah E, Cowen Philip J, Harmer Catherine J

机构信息

Department of Psychiatry, Warneford Hospital, University of Oxford, Oxford, OX3 7JX, UK.

Oxford Health NHS Foundation Trust, Oxford, UK.

出版信息

Psychopharmacology (Berl). 2025 Mar 14. doi: 10.1007/s00213-025-06770-6.

DOI:10.1007/s00213-025-06770-6
PMID:40087174
Abstract

RATIONALE

The 5-HT receptor is expressed widely across the brain and is implicated in the mechanism of action of several therapeutics for mood disorders. However, there is limited and contradictory evidence about the role of this receptor in emotional processing and cognition.

OBJECTIVES

The current study tested the acute effects of a single dose of the 5-HT agonist buspirone (20 mg), on a range of emotional processing (Emotional Test Battery) and cognitive (Auditory Verbal Learning Task (AVLT) and N-back) tasks in healthy, male and female volunteers (N = 62). The study was a randomised, double-blind, placebo controlled, parallel group design.

RESULTS

Buspirone reduced accuracy for detection of facial expressions of disgust and increased misclassification of negative facial emotions. It had no significant effects on categorisation or recall of emotionally-valanced words. Buspirone also reduced recall accuracy in the AVLT but had no significant effect in the N-back task. Participants receiving buspirone were more likely to experience nausea, light-headedness and sleepiness.

CONCLUSIONS

Acute buspirone administration produced a mild impairment in verbal memory and a subtle negative bias in emotional processing in healthy volunteers. These effects are consistent with the mixed effects of buspirone on pre- and post-synaptic 5-HT receptors.

摘要

理论依据

5-羟色胺受体在大脑中广泛表达,并与多种情绪障碍治疗药物的作用机制有关。然而,关于该受体在情绪加工和认知中的作用,证据有限且相互矛盾。

目的

本研究测试了单剂量5-羟色胺激动剂丁螺环酮(20毫克)对健康男性和女性志愿者(N = 62)一系列情绪加工(情绪测试组)和认知(听觉言语学习任务(AVLT)和N-back任务)的急性影响。该研究采用随机、双盲、安慰剂对照、平行组设计。

结果

丁螺环酮降低了对厌恶面部表情的检测准确率,并增加了对负面面部情绪的错误分类。它对情绪性词语的分类或回忆没有显著影响。丁螺环酮还降低了AVLT中的回忆准确率,但对N-back任务没有显著影响。接受丁螺环酮的参与者更容易出现恶心、头晕和嗜睡。

结论

急性给予丁螺环酮会使健康志愿者的言语记忆产生轻度损害,并在情绪加工中产生细微的负性偏差。这些效应与丁螺环酮对突触前和突触后5-羟色胺受体的混合作用一致。

相似文献

1
The behavioural effects of the serotonin 1A receptor agonist buspirone on cognition and emotional processing in healthy volunteers.血清素1A受体激动剂丁螺环酮对健康志愿者认知和情绪加工的行为影响。
Psychopharmacology (Berl). 2025 Mar 14. doi: 10.1007/s00213-025-06770-6.
2
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
3
Donepezil for dementia due to Alzheimer's disease.多奈哌齐用于治疗阿尔茨海默病所致的痴呆。
Cochrane Database Syst Rev. 2018 Jun 18;6(6):CD001190. doi: 10.1002/14651858.CD001190.pub3.
4
Folic acid with or without vitamin B12 for cognition and dementia.叶酸联合或不联合维生素B12对认知及痴呆的影响
Cochrane Database Syst Rev. 2003(4):CD004514. doi: 10.1002/14651858.CD004514.
5
Pharmacotherapies for sleep disturbances in dementia.痴呆症睡眠障碍的药物治疗
Cochrane Database Syst Rev. 2016 Nov 16;11(11):CD009178. doi: 10.1002/14651858.CD009178.pub3.
6
Pharmacotherapy for anxiety and comorbid alcohol use disorders.焦虑症合并酒精使用障碍的药物治疗
Cochrane Database Syst Rev. 2015 Jan 20;1(1):CD007505. doi: 10.1002/14651858.CD007505.pub2.
7
Augmentation Therapy With Serotonin 5-HT Receptor Partial Agonists on Cognitive Function in Depressive Disorders: A Systematic Review of Randomized Controlled Studies.5-羟色胺5-HT受体部分激动剂增强治疗对抑郁症认知功能的影响:随机对照研究的系统评价
Neuropsychopharmacol Rep. 2025 Jun;45(2):e70023. doi: 10.1002/npr2.70023.
8
Cholinesterase inhibitors for vascular dementia and other vascular cognitive impairments: a network meta-analysis.胆碱酯酶抑制剂治疗血管性痴呆和其他血管性认知障碍:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Feb 22;2(2):CD013306. doi: 10.1002/14651858.CD013306.pub2.
9
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.成人全身麻醉后预防术后恶心呕吐的药物:网状Meta分析
Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD012859. doi: 10.1002/14651858.CD012859.pub2.
10
Pramipexole in addition to mood stabilisers for treatment-resistant bipolar depression: the PAX-BD randomised double-blind placebo-controlled trial.普拉克索联合心境稳定剂治疗难治性双相抑郁:PAX - BD随机双盲安慰剂对照试验
Health Technol Assess. 2025 May;29(21):1-216. doi: 10.3310/HBFC1953.

本文引用的文献

1
The Serotonin 1A (5-HT) Receptor as a Pharmacological Target in Depression.5-羟色胺 1A(5-HT)受体在抑郁症中的药理学靶点作用。
CNS Drugs. 2023 Jul;37(7):571-585. doi: 10.1007/s40263-023-01014-7. Epub 2023 Jun 29.
2
Brain serotonin transporter is associated with cognitive-affective biases in healthy individuals.大脑血清素转运体与健康个体的认知情感偏差有关。
Hum Brain Mapp. 2022 Sep;43(13):4174-4184. doi: 10.1002/hbm.25946. Epub 2022 May 24.
3
Dysregulation of adult hippocampal neuroplasticity in major depression: pathogenesis and therapeutic implications.
重度抑郁症中成年海马神经可塑性的失调:发病机制与治疗意义。
Mol Psychiatry. 2022 Jun;27(6):2689-2699. doi: 10.1038/s41380-022-01520-y. Epub 2022 Mar 30.
4
5-HT Receptors and the Development of New Antidepressants.5-羟色胺受体与新型抗抑郁药的研发。
Int J Mol Sci. 2021 Aug 20;22(16):9015. doi: 10.3390/ijms22169015.
5
Translating biased agonists from molecules to medications: Serotonin 5-HT receptor functional selectivity for CNS disorders.从分子到药物的偏性激动剂转化:中枢神经系统疾病的血清素 5-HT 受体功能选择性。
Pharmacol Ther. 2022 Jan;229:107937. doi: 10.1016/j.pharmthera.2021.107937. Epub 2021 Jun 24.
6
An investigation of working memory deficits in depression using the n-back task: A systematic review and meta-analysis.使用 n-back 任务研究抑郁症的工作记忆缺陷:系统评价和荟萃分析。
J Affect Disord. 2021 Apr 1;284:1-8. doi: 10.1016/j.jad.2021.01.084. Epub 2021 Feb 5.
7
Distinct association of plasma BDNF concentration and cognitive function in depressed patients treated with vortioxetine or escitalopram.文拉法辛或艾司西酞普兰治疗的抑郁患者血浆脑源性神经营养因子浓度与认知功能的相关性。
Psychopharmacology (Berl). 2021 Jun;238(6):1575-1584. doi: 10.1007/s00213-021-05790-2. Epub 2021 Feb 9.
8
Effectiveness of Vortioxetine on Emotional Blunting in Patients with Major Depressive Disorder with inadequate response to SSRI/SNRI treatment.文拉法辛/去甲文拉法辛治疗反应不足的重性抑郁障碍患者中伏硫西汀对情感迟钝的疗效。
J Affect Disord. 2021 Mar 15;283:472-479. doi: 10.1016/j.jad.2020.11.106. Epub 2020 Nov 19.
9
Central 5-HT receptors and their function; present and future.中枢 5-羟色胺受体及其功能:现状与未来。
Neuropharmacology. 2020 Oct 15;177:108155. doi: 10.1016/j.neuropharm.2020.108155. Epub 2020 Jun 6.
10
Pharmacological Augmentation in Unipolar Depression: A Guide to the Guidelines.单相抑郁的药物增效治疗:指南解读。
Int J Neuropsychopharmacol. 2020 Dec 3;23(9):587-625. doi: 10.1093/ijnp/pyaa033.